Related Experiment Video
Updated: Jan 4, 2026
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
A Systems-Based Map of Human Brain Cell-Type Enriched Genes and Malignancy-Associated Endothelial Changes
Philip Dusart1, Björn Mikael Hallström2, Thomas Renné3
1Science for Life Laboratory, Department of Protein Science, Royal Institute of Technology (KTH), 171 21 Stockholm, Sweden; K.G. Jebsen Thrombosis Research and Expertise Centre, Department of Clinical Medicine, The Arctic University of Norway, 9019 Tromsø, Norway.
This study identifies brain cell-specific genes using bioinformatics and RNA sequencing. It reveals endothelial cell changes in brain tumors, offering potential biomarkers for glioblastoma.
Area of Science:
- Neuroscience
- Genomics
- Bioinformatics
Background:
- Cerebral endothelial cell alterations are implicated in neurological disorders.
- Understanding cell-type-specific gene expression is crucial for disease research.
Purpose of the Study:
- To develop a bioinformatics method for identifying normal brain cell-enriched genes.
- To characterize endothelial cell gene profiles in normal brain and malignant gliomas.
- To discover potential glioblastoma biomarkers.
Main Methods:
- Utilized bulk RNA sequencing (RNA-seq) data from 238 normal human cortex samples.
- Compared endothelial cell-enriched gene profiles with other brain cell types (astrocytes, oligodendrocytes, neurons, microglia).
- Analyzed RNA-seq data from 516 lower-grade gliomas and 401 glioblastomas.
Main Results:
- Identified normal brain cell-enriched genes, including endothelial cell profiles.
- Found that lower-grade gliomas represent an intermediate endothelial state between normal brain and glioblastoma.
- Predicted glioblastoma-specific endothelial biomarkers.
Conclusions:
- Developed a novel method to resolve cell-type-specific gene profiles from bulk RNA-seq data.
- Provided a comprehensive map of endothelial cell identity in normal and malignant brain contexts.
- Highlighted potential diagnostic and therapeutic targets for glioblastoma.
